Clinical Research Directory
Browse clinical research sites, groups, and studies.
Impact of Confirmed Autoimmune Encephalitis on Brain Glucose Metabolism
Sponsor: Assistance Publique - Hôpitaux de Paris
Summary
Prospective cohort study evaluating FDG PET in 56 patients with confirmed autoimmune encephalitis - based on 2016 Graus criteria, and 2021 paraneoplastic neurological syndromes criteria - at the acute phase, before immunomodulating treatment, or within 10 days of treatment initiation.
Official title: Impact of Confirmed Autoimmune Encephalitis on Brain Glucose Metabolism : a Prospective FDG PET Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
56
Start Date
2024-05-31
Completion Date
2026-05-31
Last Updated
2025-08-22
Healthy Volunteers
No
Conditions
Interventions
FDG PET
Brain FDG PET performed 3 months after treatment initiation
Locations (1)
Hospital Pitie Salpetriere
Paris, France